Recro Pharma

$3.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.46%) As of 7:44 PM UTC today

Why Robinhood?

You can buy or sell Recro Pharma and other stocks, options, and ETFs commission-free!

About REPH

Recro Pharma, Inc. Common Stock, also called Recro Pharma, is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). It offers solutions for the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Malvern, PA. The listed name for REPH is Recro Pharma, Inc. Common Stock.

CEO
J. David Enloe
Employees
185
Headquarters
Malvern, Pennsylvania
Founded
2007
Market Cap
109.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.10M
High Today
$3.38
Low Today
$3.20
Open Price
$3.29
Volume
173.93K
52 Week High
$10.07
52 Week Low
$1.49

REPH Earnings

-$0.48
-$0.33
-$0.18
-$0.03
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.25 per share
Actual
-$0.48 per share
Replay Earnings Call

You May Also Like

BCACU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure